Furthermore, anti-vinculin antibodies have been observed at higher levels in SSc compared with healthy controls and correlated with greater GI symptom burden (GI-VAS, p < 0.0001) [40,41,42]. The gene discussed is VCL; the disease is systemic sclerosis.